Study of Tumor Infiltrating Lymphocytes Following CCRT in the Treatment of Patients With Cervical Carcinoma

NCT04443296 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Cervical Carcinoma

Interventions

DRUG: CCRT+TIL

Sponsor

Sun Yat-sen University